Login

Unlocking Your HSA's Potential for Retirement | David Seufer, CFA of Gravitas Wealth Planning 00:10:00

Share On Facebook Share On Twitter

David Seufer is the CFA of Gravitas Wealth Planning

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Watch CNBC's full interview with Orange CEO Christel Heydemann discussing telecommunications and technology trends.
00:10:00
Billions of people got access to amazing technologies|Julie Yoo,General Partner,Andreessen Horowitz
00:10:00
Stephen Schwarzman on the Fitch Downgrade and U.S. Political Landscape | Stephen A. Schwarzman, CEO , The Blackstone Group Inc.
00:10:00
4GLOBAL PLC CEO Eloy Mazon on Data Insights and Growth | Eloy Mazon, CEO, 4GLOBAL PLC.
00:10:00
Focused solely on private equity|Saurabh Agarwal,Managing Director,Warburg Pincus LLC
00:10:00
Interview with Damien Canning | Alex Vaughan, CEO, Costain Group PLCCSGQF:PKC
00:10:00
Meet Francesco Caltagirone: Cementir Holding CEO and New Director of SUEZ | Francesco Caltagirone Jr. - CEO of Cementir Holding SpA
00:10:00
Barksdale Capital: Unlocking the Potential of Sunnyside's World-Class Base Metal Assets in Arizona
00:00:00
Fibrocell Science - Company Presentation - David Pernock, Chairman & CEO, Fibrocell Science Inc
00:10:00
Michael Rowley on Group Ten Metals' Strategic Focus on Battery Metals and PGEs in Montana's Stillwater Complex
00:10:00
Meta's Threads Launch: Strategic Insights and Market Dynamics |Roger McNamee, Co-Founder, Elevation Partners.
00:10:00
eDreams ODIGEO CEO Dana Dunne on Competing Globally While Leading Locally | Dana Dunn, CEO, eDreams ODIGEO SA.

© 2017 - Neuhu+